General Info
Brett Kaufman is an Angel Investor who is dedicated to the art and science of personal transformation, and is a firm believer in using past traumas as fuel for ambitious goals. He regularly invests in entrepreneurs and organizations, focusing on building humans and organizations holistically. While the specific Investment Focus Areas, Stage of Investment, Geographical Preference, Previous Investments, Track Record, Professional Career, and Investment Check Size were not explicitly found, it seems that Brett Kaufman’s essence lies in personal transformation and supporting ventures through a diverse and holistic approach.
Location: Columbus, Ohio, United States
Country: United States of America
Industries:
Investment Regions:
Investment Stages: pre-seed, seed
angel-individual
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: low-active
AI Reasoning: Crunchbase shows Brett Kaufman invested in Prescribe FIT with a seed/funding activity on Feb 15, 2019. The startup invested was Prescribe FIT. From that date to the reference date is over six years, which is more than 12 months, so classify as low-active.
Angel activity thresholds:
Low Activity – Only known angel investments more than 12 months ago.
Active – Known angel investments between the last 12 and 6 months.
Very Active – Known angel investments in the last 6 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Brett Kaufman

Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI
